<DOC>
	<DOC>NCT00727493</DOC>
	<brief_summary>The purpose of this study is to evaluate the influence of alendronate therapy on the wound healing after dental implants in patients with osteoporosis.</brief_summary>
	<brief_title>Osteoporosis and Dental Implant</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Postmenopausal women &gt; 2 years after menopause Age between 60 and 75 years Possibility to insert a dental implant Osteoporosis as defined by WHO criteria (intervention group), or women without osteoporosis / osteopenia (nonintervention group) Pathological findings in the jaw bone Chronic inflammatory rheumatoid disease Bisphosphonate treatments during the last 12 months Inflammatory or metabolic bone disease, excluding osteoporosis Systemic corticosteroid treatments of more than one month within previous 12 months Severe diseases with life expectancy less than one year or expectation of rapid worsening within one year</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>osteoporosis,</keyword>
	<keyword>bisphosphonate</keyword>
	<keyword>therapy</keyword>
	<keyword>dental implant</keyword>
</DOC>